Research & Development
Research & Development

Cardiovascularimaging

Cardiovascular diseases—including heart attacks, strokes, and peripheral vascular disease represent the most prevalent causes of death in developed countries. That means that any innovative cardiovascular PET imaging procedures would be of benefit for patients.

Piramal Imaging is investigating 18F-GP1, a small fluorine-18-labeled molecule for detection of activated platelets during thrombus formation. 18F-GP1 is currently in phase I of clinical development.